BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  Gain Therapeutics to Participate at ROTH Fifth Annual Healthcare Opportunities Conference

  September 17, 2026

   · 

  4 min read
• Press Releases

  MitoRx Therapeutics to present new data on MTRX31, its novel mitochondrial-targeted small molecule, at the 62nd EASD Annual Meeting 2026

  September 17, 2026

   · 

  2 min read
• Press Releases

  Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm™ (dibutepinephrine) Sublingual Film

  September 17, 2026

   · 

  8 min read
• Press Releases

  Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend - September 17, 2026

  September 17, 2026

   · 

  8 min read
• Press Releases

  CDC Highlights Significant Increase in U.S. Rabies Exposures and Anti-Rabies Immunoglobulin Utilization; Kamada Confirms Sufficient KedRAB® Supply to Meet Increased Demand

  September 17, 2026

   · 

  7 min read
• Press Releases

  Axsome Therapeutics Presents Ten Posters Exemplifying its Innovative Psychiatry and Neurology Portfolio at Psych Congress 2026

  September 17, 2026

   · 

  8 min read
• Press Releases

  Conavi Medical Announces Peer-Reviewed Case Report Highlighting Clinical Utility of Hybrid IVUS-OCT Imaging, and Provides Update on Management Team

  September 17, 2026

   · 

  7 min read
• Press Releases

  RMTG’s ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy

  September 17, 2026

   · 

  6 min read
• Press Releases

  Eterna Regeneratives Raises $4m to Pioneer a Platform for Enamel and Bone Regeneration

  September 17, 2026

   · 

  4 min read
• Press Releases

  Novo’s denecimig demonstrates tolerability after switch from emicizumab in FRONTIER5 study of people with hemophilia A as published in the Journal of Thrombosis and Haemostasis

  September 17, 2026

   · 

  13 min read